InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,548.80
(
1.37%
)
Dow Jones
42,080.37
(
0.30%
)
Brent Oil
77.26
(
-0.12%
)
Bitcoin
62,233.31
(
0.16%
)
Post# of 253309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120547
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: vieuxblue post# 6788

Sunday, 01/16/2005 8:27:18 PM

Sunday, January 16, 2005 8:27:18 PM

Post# of 253309
Re: LEXG and EXEL

I used to follow LEXG tangentially back in the days when I owned EXEL. Back then, the two companies were similar, but they have gone in different directions.

Speaking of EXEL… their recent CC to describe the changes to their collaboration with GSK was as obfuscating as ever. There is no way for investors to figure out what EXEL is really worth, and hence I’m steering clear of them despite their impressive progress in the clinic.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up